Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19 Pandemic ...Middle East

PR Newswire - News
Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19 Pandemic
BOSTON, Jan. 22, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) ("Haemonetics"), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, affirms its support of new guidance issued by the U.S. Food and Drug...

Hence then, the article about haemonetics welcomes new fda guidance on viscoelastic testing during covid 19 pandemic was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19 Pandemic )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News